The largest database of trusted experimental protocols

4 protocols using human clariom d microarrays

1

Transcriptional Changes Following SBRT

Check if the same lab product or an alternative is used in the 5 most similar protocols
Thirty-five tumor biopsies were collected prior to and/or within 7 days following SBRT, but prior to pembrolizumab, from 24 patients: 19 pre-SBRT and 16 post-SBRT (11 matched samples from the same tumor) (Table S1). RNA was extracted and analyzed using Affymetrix Human Clariom™ D microarrays. Computational gene expression deconvolution methods were used for genome-wide expression analyses following SBRT and correlated with irradiated tumor response. We utilized Ingenuity Pathway Analysis (IPA) to predict the upstream regulators of pathways involved in the gene expression changes. See Supplemental Data for details regarding baseline PD-L1 expression, microarray data pre-processing, and detection of treatment-responsive gene expression changes. A TaqMan RT-PCR assay (ThermoFisher) was used to validate DNASE1 gene expression utilizing an exon-spanning probe (Hs00173736_m1) overlapping the Clariom D transcript cluster TC1600011345.hg. Expression values for DNASE1 were normalized to the geometric mean of β-actin and 18S rRNA.
+ Open protocol
+ Expand
2

Transcriptomic Analysis of GC B Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
DAFhi and DAFlo GC B cells (CD19+ CD20+ CD38+ IgD-) were resuspended in RLT cell lysis buffer (Qiagen) after flow cytometric sorting. Total RNA was extracted (Qiagen) and microarray was performed using Affymetrix Human Clariom D microarrays (Bioinformatics and Expression Analysis core facility at Karolinska Institutet, Huddinge, Sweden). Data were analyzed in R. First the data was RMA normalized. Next, limma was used to solve the differential expression regression problems using empirical Bayes. In all cases we regressed out donor effects (~x+donor, where x is e.g. DAFhi vs DAFlo).
+ Open protocol
+ Expand
3

Cell Culture Optimization for Cancer Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
The HT29 cell line was obtained from LONZA (Basel, Switzerland). NCM460 cells were from INCELL Corporation (San Antonio, TX, USA). SW480 cells were a kind gift from Prof. Alberto Muñoz (CSIC, Madrid, Spain). Dulbecco’s modified Eagle’s medium (DMEM), penicillin, streptomycin, and fetal bovine serum (FBS) were sourced from Lonza (Basel, Switzerland). L-glutamine was from Gibco (Barcelona, Spain). Trypsin-EDTA was from LONZA (Verbiers, Belgium). Poly-L-Lysin was from Marlenfeld GmbH (Lauda-Könlgshofen, Germany). Six-well plates were from NUNC (Thermo Scientific, Waltham, MA, USA). Dishes 10 cm2 in diameter were from Corning (NY, USA). DFMO was from TOCRIS (Bristol, UK). Fura2/AM and qPCR primers are from Invitrogen (Eugene, OR, USA). Cyclopiazonic acid (CPA) was from Sigma-Aldrich (Steinheim, Alemania). Antibodies against MCU and β actin were from Sigma (Madrid, Spain). The RNA extraction kit was a GeneMATRIX Universal RNA Purification Kit from EURx (Gdansk, Poland). Clariom D human microarrays (Affymetrix) were supplied by CABIMER (Andalucía, Spain). RNA-seq (Illumina) was provided by Sistemas Genómicos S.L (Valencia, Spain). PolyamineRED was from Funakoshi Co., Ltd., Tokyo, Japan). All other reagents were obtained from Sigma and Merck.
+ Open protocol
+ Expand
4

Profiling miRNA and gene expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was extracted from cell line material using Trizol in accordance with the manufacturer’s instructions (Life Technologies, Paisley, UK). One µg of total RNA was used for Affymetrix Genechip miRNA v.4.0 microarrays, and 200 ng of DNAse treated total RNA were used for Clariom D human microarrays to measure miRNA and gene expression, respectively. The RNA was labelled and hybridised to microarrays in accordance with the manufacturer’s instructions (Affymetrix, CA, USA).
Resulting raw intensity data (i.e., cel files) were imported and analysed within Transcriptome Analysis Console (TAC) software version 4.0.2 (Affymetrix, CA, USA). Using this software, we identified differentially expressed miRNAs or genes on the basis of >2-fold up- or down-regulation along with Benjamini–Hochberg multiple corrected p values < 0.05. All microarray data was MIAME compliant, and raw data was deposited in the GEO database (GSE183140). For miRNA microarray analysis, probes were filtered for only human mature miRNAs (i.e., hsa-miR*) (* means wild-card i.e., any miR) and, for gene expression analysis coding, genes were classified as probes and filtered using the group variable ‘coding’ or ‘multiple complex’, before removing non-annotated genes that only had a numerical Aceview description.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!